img

Global HIV Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global HIV Drugs Market Report, History and Forecast 2024-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

HIV is a type of retrovirus that causes serious complications in humans. It generally spreads via the blood, semen, vaginal fluid, pre-ejaculate, or breast milk. The global market for HIV drugs is envisaged to surpass USD 19,000 million by 2019 owing to the recent rise in HIV patient population.
HIV Drugs report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global HIV Drugs market is projected to reach US$ 26950 million in 2034, increasing from US$ 23380 million in 2022, with the CAGR of 2.0% during the period of 2024 to 2034. Demand from Hospital Pharmacies and Retail Pharmacies are the major drivers for the industry.
One of the primary factors catalyzing the growth of the global HIV drugs market is increase in the prevalence of HIV and its diagnosis. Apart from this, the market is also influenced by a rise in the number of government initiatives for spreading the awareness amongst people regarding causes, symptoms and treatments. Moreover, the introduction of generic drugs, which are cost-effective and chemically identical to branded drugs, act as another factor that is contributing towards the demand for HIV drugs.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global HIV Drugs market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Bristol-Myers Squibb
Gilead Sciences
GlaxoSmithKline
Johnson & Johnson
Merck
Segment by Type
Multi-Class Combination Products
Nucleoside Reverse Transcriptase Inhibitors
Non-Nucleoside Reverse Transcriptase Inhibitors
Protease Inhibitors
Fusion Inhibitors
Entry Inhibitors - CCR5 Co-Receptor Antagonist
HIV Integrase Strand Transfer Inhibitors

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others

Segment by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Each chapter of the report provides detailed information for readers to understand the HIV Drugs market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of HIV Drugs, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the HIV Drugs industry.
Chapter 3Historical (2024-2022) and forecast (2024-2034) volume and revenue analysis of HIV Drugs in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, HIV Drugs introduction, etc. HIV Drugs Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of HIV Drugs market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 HIV Drugs Market Overview
1.1 HIV Drugs Product Overview
1.2 HIV Drugs Market Segment by Type
1.2.1 Multi-Class Combination Products
1.2.2 Nucleoside Reverse Transcriptase Inhibitors
1.2.3 Non-Nucleoside Reverse Transcriptase Inhibitors
1.2.4 Protease Inhibitors
1.2.5 Fusion Inhibitors
1.2.6 Entry Inhibitors - CCR5 Co-Receptor Antagonist
1.2.7 HIV Integrase Strand Transfer Inhibitors
1.3 Global HIV Drugs Market Size by Type
1.3.1 Global HIV Drugs Market Size Overview by Type (2024-2034)
1.3.2 Global HIV Drugs Historic Market Size Review by Type (2024-2024)
1.3.3 Global HIV Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America HIV Drugs Sales Breakdown by Type (2024-2024)
1.4.2 Europe HIV Drugs Sales Breakdown by Type (2024-2024)
1.4.3 Asia-Pacific HIV Drugs Sales Breakdown by Type (2024-2024)
1.4.4 Latin America HIV Drugs Sales Breakdown by Type (2024-2024)
1.4.5 Middle East and Africa HIV Drugs Sales Breakdown by Type (2024-2024)
2 Global HIV Drugs Market Competition by Company
2.1 Global Top Players by HIV Drugs Sales (2024-2024)
2.2 Global Top Players by HIV Drugs Revenue (2024-2024)
2.3 Global Top Players by HIV Drugs Price (2024-2024)
2.4 Global Top Manufacturers HIV Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 HIV Drugs Market Competitive Situation and Trends
2.5.1 HIV Drugs Market Concentration Rate (2024-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by HIV Drugs Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Drugs as of 2022)
2.7 Date of Key Manufacturers Enter into HIV Drugs Market
2.8 Key Manufacturers HIV Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 HIV Drugs Status and Outlook by Region
3.1 Global HIV Drugs Market Size and CAGR by Region: 2024 VS 2022 VS 2034
3.2 Global HIV Drugs Historic Market Size by Region
3.2.1 Global HIV Drugs Sales in Volume by Region (2024-2024)
3.2.2 Global HIV Drugs Sales in Value by Region (2024-2024)
3.2.3 Global HIV Drugs Sales (Volume & Value) Price and Gross Margin (2024-2024)
3.3 Global HIV Drugs Forecasted Market Size by Region
3.3.1 Global HIV Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global HIV Drugs Sales in Value by Region (2024-2034)
3.3.3 Global HIV Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global HIV Drugs by Application
4.1 HIV Drugs Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.1.4 Others
4.2 Global HIV Drugs Market Size by Application
4.2.1 Global HIV Drugs Market Size Overview by Application (2024-2034)
4.2.2 Global HIV Drugs Historic Market Size Review by Application (2024-2024)
4.2.3 Global HIV Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America HIV Drugs Sales Breakdown by Application (2024-2024)
4.3.2 Europe HIV Drugs Sales Breakdown by Application (2024-2024)
4.3.3 Asia-Pacific HIV Drugs Sales Breakdown by Application (2024-2024)
4.3.4 Latin America HIV Drugs Sales Breakdown by Application (2024-2024)
4.3.5 Middle East and Africa HIV Drugs Sales Breakdown by Application (2024-2024)
5 North America HIV Drugs by Country
5.1 North America HIV Drugs Historic Market Size by Country
5.1.1 North America HIV Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
5.1.2 North America HIV Drugs Sales in Volume by Country (2024-2024)
5.1.3 North America HIV Drugs Sales in Value by Country (2024-2024)
5.2 North America HIV Drugs Forecasted Market Size by Country
5.2.1 North America HIV Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America HIV Drugs Sales in Value by Country (2024-2034)
6 Europe HIV Drugs by Country
6.1 Europe HIV Drugs Historic Market Size by Country
6.1.1 Europe HIV Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
6.1.2 Europe HIV Drugs Sales in Volume by Country (2024-2024)
6.1.3 Europe HIV Drugs Sales in Value by Country (2024-2024)
6.2 Europe HIV Drugs Forecasted Market Size by Country
6.2.1 Europe HIV Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe HIV Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific HIV Drugs by Region
7.1 Asia-Pacific HIV Drugs Historic Market Size by Region
7.1.1 Asia-Pacific HIV Drugs Market Size Growth Rate (CAGR) by Region: 2024 VS 2022 VS 2034
7.1.2 Asia-Pacific HIV Drugs Sales in Volume by Region (2024-2024)
7.1.3 Asia-Pacific HIV Drugs Sales in Value by Region (2024-2024)
7.2 Asia-Pacific HIV Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific HIV Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific HIV Drugs Sales in Value by Region (2024-2034)
8 Latin America HIV Drugs by Country
8.1 Latin America HIV Drugs Historic Market Size by Country
8.1.1 Latin America HIV Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
8.1.2 Latin America HIV Drugs Sales in Volume by Country (2024-2024)
8.1.3 Latin America HIV Drugs Sales in Value by Country (2024-2024)
8.2 Latin America HIV Drugs Forecasted Market Size by Country
8.2.1 Latin America HIV Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America HIV Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa HIV Drugs by Country
9.1 Middle East and Africa HIV Drugs Historic Market Size by Country
9.1.1 Middle East and Africa HIV Drugs Market Size Growth Rate (CAGR) by Country: 2024 VS 2022 VS 2034
9.1.2 Middle East and Africa HIV Drugs Sales in Volume by Country (2024-2024)
9.1.3 Middle East and Africa HIV Drugs Sales in Value by Country (2024-2024)
9.2 Middle East and Africa HIV Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa HIV Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa HIV Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Company Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb HIV Drugs Sales, Revenue and Gross Margin (2024-2024)
10.1.4 Bristol-Myers Squibb HIV Drugs Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 Gilead Sciences
10.2.1 Gilead Sciences Company Information
10.2.2 Gilead Sciences Introduction and Business Overview
10.2.3 Gilead Sciences HIV Drugs Sales, Revenue and Gross Margin (2024-2024)
10.2.4 Gilead Sciences HIV Drugs Products Offered
10.2.5 Gilead Sciences Recent Development
10.3 GlaxoSmithKline
10.3.1 GlaxoSmithKline Company Information
10.3.2 GlaxoSmithKline Introduction and Business Overview
10.3.3 GlaxoSmithKline HIV Drugs Sales, Revenue and Gross Margin (2024-2024)
10.3.4 GlaxoSmithKline HIV Drugs Products Offered
10.3.5 GlaxoSmithKline Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson HIV Drugs Sales, Revenue and Gross Margin (2024-2024)
10.4.4 Johnson & Johnson HIV Drugs Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Merck
10.5.1 Merck Company Information
10.5.2 Merck Introduction and Business Overview
10.5.3 Merck HIV Drugs Sales, Revenue and Gross Margin (2024-2024)
10.5.4 Merck HIV Drugs Products Offered
10.5.5 Merck Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 HIV Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 HIV Drugs Industrial Chain Analysis
11.4 HIV Drugs Market Dynamics
11.4.1 HIV Drugs Industry Trends
11.4.2 HIV Drugs Market Drivers
11.4.3 HIV Drugs Market Challenges
11.4.4 HIV Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 HIV Drugs Distributors
12.3 HIV Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Multi-Class Combination Products
Table 2. Major Company of Nucleoside Reverse Transcriptase Inhibitors
Table 3. Major Company of Non-Nucleoside Reverse Transcriptase Inhibitors
Table 4. Major Company of Protease Inhibitors
Table 5. Major Company of Fusion Inhibitors
Table 6. Major Company of Entry Inhibitors - CCR5 Co-Receptor Antagonist
Table 7. Major Company of HIV Integrase Strand Transfer Inhibitors
Table 8. Global HIV Drugs Sales by Type 2024 VS 2022 VS 2034 (US$ Million)
Table 9. Global HIV Drugs Sales by Type (2024-2024) & (K Units)
Table 10. Global HIV Drugs Sales Market Share in Volume by Type (2024-2024)
Table 11. Global HIV Drugs Sales by Type (2024-2024) & (US& Million)
Table 12. Global HIV Drugs Market Share in Value by Type (2024-2024)
Table 13. Global HIV Drugs Price by Type (2024-2024) & (USD/Unit)
Table 14. Global HIV Drugs Sales by Type (2024-2034) & (K Units)
Table 15. Global HIV Drugs Sales Market Share in Volume by Type (2024-2034)
Table 16. Global HIV Drugs Sales by Type (2024-2034) & (US$ Million)
Table 17. Global HIV Drugs Sales Market Share in Value by Type (2024-2034)
Table 18. Global HIV Drugs Price by Type (2024-2034) & (USD/Unit)
Table 19. North America HIV Drugs Sales by Type (2024-2024) & (K Units)
Table 20. North America HIV Drugs Sales by Type (2024-2024) & (US$ Million)
Table 21. Europe HIV Drugs Sales (K Units) by Type (2024-2024)
Table 22. Europe HIV Drugs Sales by Type (2024-2024) & (US$ Million)
Table 23. Asia-Pacific HIV Drugs Sales (K Units) by Type (2024-2024)
Table 24. Asia-Pacific HIV Drugs Sales by Type (2024-2024) & (US$ Million)
Table 25. Latin America HIV Drugs Sales (K Units) by Type (2024-2024)
Table 26. Latin America HIV Drugs Sales by Type (2024-2024) & (US$ Million)
Table 27. Middle East and Africa HIV Drugs Sales (K Units) by Type (2024-2024)
Table 28. Middle East and Africa HIV Drugs Sales by Type (2024-2024) & (US$ Million)
Table 29. Global HIV Drugs Sales by Company (2024-2024) & (K Units)
Table 30. Global HIV Drugs Sales Share by Company (2024-2024)
Table 31. Global HIV Drugs Revenue by Company (2024-2024) & (US$ Million)
Table 32. Global HIV Drugs Revenue Share by Company (2024-2024)
Table 33. Global Market HIV Drugs Price by Company (2024-2024) & (USD/Unit)
Table 34. Global HIV Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 35. Global HIV Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 36. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in HIV Drugs as of 2022)
Table 37. Date of Key Manufacturers Enter into HIV Drugs Market
Table 38. Key Manufacturers HIV Drugs Product Type
Table 39. Mergers & Acquisitions, Expansion Plans
Table 40. Global HIV Drugs Market Size Comparison by Region (US$ Million): 2024 VS 2022 VS 2034
Table 41. Global HIV Drugs Sales by Region (2024-2024) & (K Units)
Table 42. Global HIV Drugs Sales Market Share in Volume by Region (2024-2024)
Table 43. Global HIV Drugs Sales by Region (2024-2024) & (US$ Million)
Table 44. Global HIV Drugs Sales Market Share in Value by Region (2024-2024)
Table 45. Global HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2024)
Table 46. Global HIV Drugs Sales by Region (2024-2034) & (K Units)
Table 47. Global HIV Drugs Sales Market Share in Volume by Region (2024-2034)
Table 48. Global HIV Drugs Sales by Region (2024-2034) & (US$ Million)
Table 49. Global HIV Drugs Sales Market Share in Value by Region (2024-2034)
Table 50. Global HIV Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 51. Global HIV Drugs Sales by Application: 2024 VS 2022 VS 2034 (US$ Million)
Table 52. Global HIV Drugs Sales by Application (2024-2024) & (K Units)
Table 53. Global HIV Drugs Sales Market Share in Volume by Application (2024-2024)
Table 54. Global HIV Drugs Sales by Application (2024-2024) & (US$ Million)
Table 55. Global HIV Drugs Sales Market Share in Value by Application (2024-2024)
Table 56. Global HIV Drugs Price by Application (2024-2024) & (USD/Unit)
Table 57. Global HIV Drugs Sales by Application (2024-2034) & (K Units)
Table 58. Global HIV Drugs Sales Market Share in Volume by Application (2024-2034)
Table 59. Global HIV Drugs Sales by Application (2024-2034) & (US$ Million)
Table 60. Global HIV Drugs Sales Market Share in Value by Application (2024-2034)
Table 61. Global HIV Drugs Price by Application (2024-2034) & (USD/Unit)
Table 62. North America HIV Drugs Sales by Application (2024-2024) (K Units)
Table 63. North America HIV Drugs Sales by Application (2024-2024) & (US$ Million)
Table 64. Europe HIV Drugs Sales by Application (2024-2024) (K Units)
Table 65. Europe HIV Drugs Sales by Application (2024-2024) & (US$ Million)
Table 66. Asia-Pacific HIV Drugs Sales by Application (2024-2024) (K Units)
Table 67. Asia-Pacific HIV Drugs Sales by Application (2024-2024) & (US$ Million)
Table 68. Latin America HIV Drugs Sales by Application (2024-2024) (K Units)
Table 69. Latin America HIV Drugs Sales by Application (2024-2024) & (US$ Million)
Table 70. Middle East and Africa HIV Drugs Sales by Application (2024-2024) (K Units)
Table 71. Middle East and Africa HIV Drugs Sales by Application (2024-2024) & (US$ Million)
Table 72. North America HIV Drugs Sales by Country (2024-2024) & (K Units)
Table 73. North America HIV Drugs Sales Market Share in Volume by Country (2024-2024)
Table 74. North America HIV Drugs Sales by Country (2024-2024) & (US$ Million)
Table 75. North America HIV Drugs Sales Market Share in Value by Country (2024-2024)
Table 76. North America HIV Drugs Sales by Country (2024-2034) & (K Units)
Table 77. North America HIV Drugs Sales Market Share in Volume by Country (2024-2034)
Table 78. North America HIV Drugs Sales by Country (2024-2034) & (US$ Million)
Table 79. North America HIV Drugs Sales Market Share in Value by Country (2024-2034)
Table 80. Europe HIV Drugs Sales by Country (2024-2024) & (K Units)
Table 81. Europe HIV Drugs Sales Market Share in Volume by Country (2024-2024)
Table 82. Europe HIV Drugs Sales by Country (2024-2024) & (US$ Million)
Table 83. Europe HIV Drugs Sales Market Share in Value by Country (2024-2024)
Table 84. Europe HIV Drugs Sales by Country (2024-2034) & (K Units)
Table 85. Europe HIV Drugs Sales Market Share in Volume by Country (2024-2034)
Table 86. Europe HIV Drugs Sales by Country (2024-2034) & (US$ Million)
Table 87. Europe HIV Drugs Sales Market Share in Value by Country (2024-2034)
Table 88. Asia-Pacific HIV Drugs Sales by Region (2024-2024) & (K Units)
Table 89. Asia-Pacific HIV Drugs Sales Market Share in Volume by Region (2024-2024)
Table 90. Asia-Pacific HIV Drugs Sales by Region (2024-2024) & (US$ Million)
Table 91. Asia-Pacific HIV Drugs Sales Market Share in Value by Region (2024-2024)
Table 92. Asia-Pacific HIV Drugs Sales by Region (2024-2034) & (K Units)
Table 93. Asia-Pacific HIV Drugs Sales Market Share in Volume by Region (2024-2034)
Table 94. Asia-Pacific HIV Drugs Sales by Region (2024-2034) & (US$ Million)
Table 95. Asia-Pacific HIV Drugs Sales Market Share in Value by Region (2024-2034)
Table 96. Latin America HIV Drugs Sales by Country (2024-2024) & (K Units)
Table 97. Latin America HIV Drugs Sales Market Share in Volume by Country (2024-2024)
Table 98. Latin America HIV Drugs Sales by Country (2024-2024) & (US$ Million)
Table 99. Latin America HIV Drugs Sales Market Share in Value by Country (2024-2024)
Table 100. Latin America HIV Drugs Sales by Country (2024-2034) & (K Units)
Table 101. Latin America HIV Drugs Sales Market Share in Volume by Country (2024-2034)
Table 102. Latin America HIV Drugs Sales by Country (2024-2034) & (US$ Million)
Table 103. Latin America HIV Drugs Sales Market Share in Value by Country (2024-2034)
Table 104. Middle East and Africa HIV Drugs Sales by Country (2024-2024) & (K Units)
Table 105. Middle East and Africa HIV Drugs Sales Market Share in Volume by Country (2024-2024)
Table 106. Middle East and Africa HIV Drugs Sales by Country (2024-2024) & (US$ Million)
Table 107. Middle East and Africa HIV Drugs Sales Market Share in Value by Country (2024-2024)
Table 108. Middle East and Africa HIV Drugs Sales by Country (2024-2034) & (K Units)
Table 109. Middle East and Africa HIV Drugs Sales Market Share in Volume by Country (2024-2034)
Table 110. Middle East and Africa HIV Drugs Sales by Country (2024-2034) & (US$ Million)
Table 111. Middle East and Africa HIV Drugs Sales Market Share in Value by Country (2024-2034)
Table 112. Bristol-Myers Squibb Company Information
Table 113. Bristol-Myers Squibb Introduction and Business Overview
Table 114. Bristol-Myers Squibb HIV Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 115. Bristol-Myers Squibb HIV Drugs Product
Table 116. Bristol-Myers Squibb Recent Development
Table 117. Gilead Sciences Company Information
Table 118. Gilead Sciences Introduction and Business Overview
Table 119. Gilead Sciences HIV Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 120. Gilead Sciences HIV Drugs Product
Table 121. Gilead Sciences Recent Development
Table 122. GlaxoSmithKline Company Information
Table 123. GlaxoSmithKline Introduction and Business Overview
Table 124. GlaxoSmithKline HIV Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 125. GlaxoSmithKline HIV Drugs Product
Table 126. GlaxoSmithKline Recent Development
Table 127. Johnson & Johnson Company Information
Table 128. Johnson & Johnson Introduction and Business Overview
Table 129. Johnson & Johnson HIV Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 130. Johnson & Johnson HIV Drugs Product
Table 131. Johnson & Johnson Recent Development
Table 132. Merck Company Information
Table 133. Merck Introduction and Business Overview
Table 134. Merck HIV Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2024-2024)
Table 135. Merck HIV Drugs Product
Table 136. Merck Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. HIV Drugs Market Trends
Table 140. HIV Drugs Market Drivers
Table 141. HIV Drugs Market Challenges
Table 142. HIV Drugs Market Restraints
Table 143. HIV Drugs Distributors List
Table 144. HIV Drugs Downstream Customers
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. HIV Drugs Product Picture
Figure 2. Global HIV Drugs Market Size, 2024 VS 2022 VS 2034 (US$ Million)
Figure 3. Global HIV Drugs Market Size Status and Outlook (2024-2034) & (US$ Million)
Figure 4. Global HIV Drugs Sales Status and Outlook (2024-2034) & (K Units)
Figure 5. Product Picture of Multi-Class Combination Products
Figure 6. Global Multi-Class Combination Products Sales YoY Growth (2024-2034) & (K Units)
Figure 7. Product Picture of Nucleoside Reverse Transcriptase Inhibitors
Figure 8. Global Nucleoside Reverse Transcriptase Inhibitors Sales YoY Growth (2024-2034) & (K Units)
Figure 9. Product Picture of Non-Nucleoside Reverse Transcriptase Inhibitors
Figure 10. Global Non-Nucleoside Reverse Transcriptase Inhibitors Sales YoY Growth (2024-2034) & (K Units)
Figure 11. Product Picture of Protease Inhibitors
Figure 12. Global Protease Inhibitors Sales YoY Growth (2024-2034) & (K Units)
Figure 13. Product Picture of Fusion Inhibitors
Figure 14. Global Fusion Inhibitors Sales YoY Growth (2024-2034) & (K Units)
Figure 15. Product Picture of Entry Inhibitors - CCR5 Co-Receptor Antagonist
Figure 16. Global Entry Inhibitors - CCR5 Co-Receptor Antagonist Sales YoY Growth (2024-2034) & (K Units)
Figure 17. Product Picture of HIV Integrase Strand Transfer Inhibitors
Figure 18. Global HIV Integrase Strand Transfer Inhibitors Sales YoY Growth (2024-2034) & (K Units)
Figure 19. Global HIV Drugs Sales by Type (2024-2034) & (US$ Million)
Figure 20. Global HIV Drugs Sales Market Share by Type in 2022 & 2034
Figure 21. North America HIV Drugs Sales Market Share in Volume by Type in 2022
Figure 22. North America HIV Drugs Sales Market Share in Value by Type in 2022
Figure 23. Europe HIV Drugs Sales Market Share in Volume by Type in 2022
Figure 24. Europe HIV Drugs Sales Market Share in Value by Type in 2022
Figure 25. Asia-Pacific HIV Drugs Sales Market Share in Volume by Type in 2022
Figure 26. Asia-Pacific HIV Drugs Sales Market Share in Value by Type in 2022
Figure 27. Latin America HIV Drugs Sales Market Share in Volume by Type in 2022
Figure 28. Latin America HIV Drugs Sales Market Share in Value by Type in 2022
Figure 29. Middle East and Africa HIV Drugs Sales Market Share in Volume by Type in 2022
Figure 30. Middle East and Africa HIV Drugs Sales Market Share in Value by Type in 2022
Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by HIV Drugs Sales in 2022
Figure 32. The 5 and 10 Largest Manufacturers in the World: Market Share by HIV Drugs Revenue in 2022
Figure 33. HIV Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2024 VS 2022
Figure 34. Product Picture of Hospital Pharmacies
Figure 35. Global Hospital Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 36. Product Picture of Retail Pharmacies
Figure 37. Global Retail Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 38. Product Picture of Online Pharmacies
Figure 39. Global Online Pharmacies Sales YoY Growth (2024-2034) & (K Units)
Figure 40. Product Picture of Others
Figure 41. Global Others Sales YoY Growth (2024-2034) & (K Units)
Figure 42. Global HIV Drugs Sales by Application (2024-2034) & (US$ Million)
Figure 43. Global HIV Drugs Sales Market Share by Application in 2022 & 2034
Figure 44. North America HIV Drugs Sales Market Share in Volume by Application in 2022
Figure 45. North America HIV Drugs Sales Market Share in Value by Application in 2022
Figure 46. Europe HIV Drugs Sales Market Share in Volume by Application in 2022
Figure 47. Europe HIV Drugs Sales Market Share in Value by Application in 2022
Figure 48. Asia-Pacific HIV Drugs Sales Market Share in Volume by Application in 2022
Figure 49. Asia-Pacific HIV Drugs Sales Market Share in Value by Application in 2022
Figure 50. Latin America HIV Drugs Sales Market Share in Volume by Application in 2022
Figure 51. Latin America HIV Drugs Sales Market Share in Value by Application in 2022
Figure 52. Middle East and Africa HIV Drugs Sales Market Share in Value by Application in 2022
Figure 53. Key Raw Materials Price
Figure 54. HIV Drugs Manufacturing Cost Structure
Figure 55. HIV Drugs Industrial Chain Analysis
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries